CCM
IDXX icon

Cribstone Capital Management’s Idexx Laboratories IDXX Stock Holding History

Cribstone Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.92M Buy
4,698
+236
+5% +$91.6K 1.12% 27
2022
Q3 		$1.45M Sell
4,462
-106
-2% -$38.9K 0.9% 30
2022
Q2 		$1.6M Buy
4,568
+409
+10% +$167K 0.99% 27
2022
Q1 		$2.27M Buy
4,159
+73
+2% +$38.4K 1.24% 20
2021
Q4 		$2.69M Buy
4,086
+42
+1% +$26.4K 1.49% 18
2021
Q3 		$2.52M Sell
4,044
-94
-2% -$63.2K 1.5% 18
2021
Q2 		$2.61M Buy
4,138
+18
+0.4% +$9.94K 1.59% 16
2021
Q1 		$2.02M Sell
4,120
-1,110
-21% -$556K 1.33% 22
2020
Q4 		$2.61M Buy
5,230
+12
+0.2% +$5.37K 1.79% 15
2020
Q3 		$2.05M Sell
5,218
-822
-14% -$304K 1.68% 16
2020
Q2 		$1.99M Sell
6,040
-125
-2% -$36.2K 1.65% 16
2020
Q1 		$1.49M Sell
6,165
-155
-2% -$40.5K 1.58% 17
2019
Q4 		$1.65M Sell
6,320
-4,211
-40% -$1.11M 1.48% 21
2019
Q3 		$2.86M Sell
10,531
-720
-6% -$200K 1.73% 15
2019
Q2 		$3.1M Sell
11,251
-523
-4% -$129K 1.69% 17
2019
Q1 		$2.63M Sell
11,774
-2,350
-17% -$485K 1.39% 20
2018
Q4 		$2.63M Buy
14,124
+510
+4% +$105K 1.34% 22
2018
Q3 		$3.4M Sell
13,614
-33
-0.2% -$8.01K 1.56% 16
2018
Q2 		$2.97M Sell
13,647
-409
-3% -$84.3K 1.46% 16
2018
Q1 		$2.69M Sell
14,056
-287
-2% -$53K 1.32% 17
2017
Q4 		$2.24M Buy
14,343
+1,829
+15% +$288K 1.06% 26
2017
Q3 		$1.95M Sell
12,514
-118
-0.9% -$18.7K 1.02% 28
2017
Q2 		$2.04M Sell
12,632
-377
-3% -$61.2K 1.11% 23
2017
Q1 		$2.02M Sell
13,009
-259
-2% -$35.7K 1.1% 21
2016
Q4 		$1.58M Sell
13,268
-703
-5% -$80.2K 0.96% 25
2016
Q3 		$1.55M Sell
13,971
-767
-5% -$80.8K 0.95% 29
2016
Q2 		$1.37M Sell
14,738
-287
-2% -$24.6K 0.85% 35
2016
Q1 		$1.18M Buy
15,025
+516
+4% +$37.2K 0.95% 35
2015
Q4 		$1.06M Buy
+14,509
New +$1.03M 0.87% 37

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cribstone Capital Management's IDXX Position: Q4 2022 in Review

Cribstone Capital Management increased its Idexx Laboratories (IDXX) stake by 5.3% in Q4 2022, buying an estimated $91.6K and bringing the position to 4,698 shares worth $1.92M. The position accounts for 1.12% of the portfolio, ranked #27.

Cribstone Capital Management first reported a position in IDXX in Q4 2015 and has held it in 29 quarters since. The position peaked at $3.4M in Q3 2018. 1,000 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • Cribstone Capital Management held 4,698 shares of Idexx Laboratories worth $1.92M as of Q4 2022.
  • Cribstone Capital Management bought 236 Idexx Laboratories shares in Q4 2022, an estimated $91.6K.
  • Idexx Laboratories made up 1.12% of Cribstone Capital Management's portfolio in Q4 2022, its #27 holding.
  • Cribstone Capital Management first reported a position in Idexx Laboratories in Q4 2015 and has held it in 29 quarters since.
  • Cribstone Capital Management's Idexx Laboratories position peaked at $3.4M in Q3 2018.
  • 1,000 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.